PTX 2.56% 3.8¢ prescient therapeutics limited

Ann: Third complete response in PTX-200 AML Trial, page-113

  1. 3,040 Posts.
    lightbulb Created with Sketch. 403
    I usually agree with u mate but must say 3/15 patients is very poor success rate. I'm not buying it. A potential cancer cure is to cure all patients not 20%. That's not how drugs are given the green light but then again they will alter their dosage etc so for holders sake I hope the stats are better next time. Happy for u though. Not here to downramp. I stated everything that was mentioned in today's company report taken directly from the announcement. I suppose my medical skill sets and interpretation compared to an everyday investor's interpretation is vastly different.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $30.60M
Open High Low Value Volume
3.9¢ 3.9¢ 3.8¢ $47.91K 1.256M

Buyers (Bids)

No. Vol. Price($)
11 881755 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 150000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.